We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Molecular genetic screening of full-term small for gestational age

    Objective

    To examine the clinical application of genomic screening in newborns small for gestational age (SGA), ho** to provide an efficient...

    Shuman Zhang, Lingna Zhou, ... Huaiyan Wang in BMC Pediatrics
    Article Open access 05 May 2023
  2. Guanxin V Relieves Ventricular Remodeling by Inhibiting Inflammation: Implication from Virtual Screening, Systematic Pharmacology, Molecular Docking, and Experimental Validation

    Objective

    To reveal the anti-inflammatory mechanism of Guanxin V, which is prescribed for ventricular remodeling in clinical practice.

    ...
    Bo Liang, **ao-xiao Zhang, Ning Gu in Chinese Journal of Integrative Medicine
    Article 02 August 2023
  3. Diagnostic value of molecular approach in screening for fragile X premutation cases

    Background

    Fragile X syndrome (FXS) is the most common form of inherited intellectual disability, caused by CGG-repeats expansion (> 200 repeats)....

    Miral M. Refeat, Mostafa M. El Saied, Ehab R. Abdel Raouf in Irish Journal of Medical Science (1971 -)
    Article Open access 21 November 2022
  4. Virtual screening–molecular docking–activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis

    Background

    The dried bark of Ailanthus altissima (Mill.) Swingle is widely used in traditional Chinese medicine for the treatment of ulcerative...

    Shan-bo Ma, Lun Liu, ... Si-wang Wang in BMC Complementary Medicine and Therapies
    Article Open access 15 June 2023
  5. Identification of novel AKT1 inhibitors from Sapria himalayana bioactive compounds using structure-based virtual screening and molecular dynamics simulations

    Through the experimental and computational analyses, the present study sought to elucidate the chemical composition and anticancer potential of Sapria...

    Laldinfeli Ralte, Hmingremhlua Sailo, ... Yengkhom Tunginba Singh in BMC Complementary Medicine and Therapies
    Article Open access 07 March 2024
  6. A direct, sensitive and high-throughput genus and species-specific molecular assay for large-scale malaria screening

    Background

    Infectious disease diagnostics often requires sensitive molecular assays that identify at both genus and species levels. For large scale...

    Yaling Zhao, Ye Zhao, ... Zhi Zheng in Infectious Diseases of Poverty
    Article Open access 07 March 2022
  7. Das Prostatakarzinom-Screening – aktueller Überblick

    Background

    The harm-to-benefit ratio of prostate cancer (PCa) screening remains controversial mainly due to the unfavorable test characteristics of...

    Maxime De Vrieze, Anne Hübner, ... Matthias Boschheidgen in Die Radiologie
    Article 14 May 2024
  8. Supplemental Screening for Breast Cancer

    Purpose of Review

    Increased breast density, among other calculated risk factors, decreases the sensitivity of screening mammography. Several...

    Charles De Jesus, Tanya W. Moseley, ... Miral M. Patel in Current Breast Cancer Reports
    Article 04 April 2023
  9. Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women

    Purpose

    There are insufficient large-scale studies comparing the performance of screening mammography in women of different races. This study aims to...

    Cindy S. Lee, Lenka Goldman, ... Linda Moy in Breast Cancer Research and Treatment
    Article 28 October 2023
  10. A practical approach to screening for carbapenemase-producing Enterobacterales– views of a group of multidisciplinary experts from English hospitals

    Introduction

    Carbapenemase-producing Enterobacterales (CPE) are an important public health threat, with costly operational and economic consequences...

    DR. Jenkins, C. Auckland, ... T. Whalley in BMC Infectious Diseases
    Article Open access 26 April 2024
  11. Evaluation of a population-based breast cancer screening in North China

    Background

    Despite mammography-based screening for breast cancer has been conducted in many countries, there are still little data on participation...

    Siqi Wu, Di Liang, ... Yutong He in Journal of Cancer Research and Clinical Oncology
    Article Open access 02 June 2023
  12. Virtual screening, pharmacokinetics, and molecular dynamics simulations studies to identify potent approved drugs for Chlamydia trachomatis treatment

    Background

    The most frequent bacterial sexually transmitted disease is Chlamydia trachomatis (STD). In 2010, the Centers for Disease Control and...

    Emmanuel Israel Edache, Adamu Uzairu, ... Paul Andrew Mamza in Future Journal of Pharmaceutical Sciences
    Article Open access 30 October 2021
  13. A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases

    Purpose

    Brain metastases represent the most common intracranial tumors in adults and are associated with a poor prognosis. We used a personalized in...

    Sebastian Jeising, Ann-Christin Nickel, ... Nan Qin in Journal of Neuro-Oncology
    Article Open access 10 July 2024
  14. Specificity of serological screening tests and reference laboratory tests to diagnose gambiense human African trypanosomiasis: a prospective clinical performance study

    Background

    Serological screening tests play a crucial role to diagnose gambiense human African trypanosomiasis (gHAT). Presently, they preselect...

    Martial Kassi N’Djetchi, Oumou Camara, ... Veerle Lejon in Infectious Diseases of Poverty
    Article Open access 08 July 2024
  15. A decade of molecular preimplantation genetic diagnosis of 350 blastomeres for beta-thalassemia combined with HLA ty**, aneuploidy screening and sex selection in Iran

    Background

    Preimplantation genetic diagnosis (PGD) has been developed to detect genetic disorders before pregnancy which is usually done on...

    Yeganeh Keshvar, Solmaz Sabeghi, ... Sirous Zeinali in BMC Pregnancy and Childbirth
    Article Open access 15 April 2022
  16. Breast cancer stage and molecular subtype distribution: real-world insights from a regional oncological center in Hungary

    Objective

    Examining the distribution of breast cancer (BC) stage and molecular subtype among women aged below (< 45 years), within (45–65 years), and...

    Judit Tittmann, Tamás Ágh, ... Zoltán Vokó in Discover Oncology
    Article Open access 22 June 2024
  17. Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances

    Background

    Esophageal squamous cell carcinoma (ESCC) is one of the most common tumors in the gastrointestinal tract, and China has a high incidence...

    **ao Mou, Zhenglin Peng, ... **ngwang Sun in Journal of Gastrointestinal Cancer
    Article 04 November 2023
  18. Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements

    Background

    NRG1 fusion is a promising therapeutic target for various tumors but its prevalence is extremely low, and there are no standardized testing...

    **aomei Zhang, Lin Li, ... Qing Ye in Diagnostic Pathology
    Article Open access 03 January 2024
  19. Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68–69

    Objective

    The European Commission Initiative on Breast Cancer recommendation for triennial screening of women aged 70–74 is based on very weak...

    Lauro Bucchi, Alessandra Ravaioli, ... Fabio Falcini in European Radiology
    Article 06 August 2021
  20. Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS)

    To assess their roles in breast cancer diagnostics, we aimed to compare plasma cell-free DNA (cfDNA) levels with the circulating metabolome in a...

    Justin Stebbing, Panteleimon G. Takis, ... Jacqueline A. Shaw in Oncogene
    Article Open access 24 January 2023
Did you find what you were looking for? Share feedback.